151 related articles for article (PubMed ID: 25303803)
1. Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment.
Kim MK; Yun KJ; Chun HJ; Jang EH; Han KD; Park YM; Baek KH; Song KH; Cha BY; Park CS; Kwon HS
Diabetes Metab; 2014 Dec; 40(6):459-65. PubMed ID: 25303803
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients.
Cardoso CR; Marques CE; Leite NC; Salles GF
J Hypertens; 2012 May; 30(5):940-7. PubMed ID: 22495135
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of beta-2-microglobulin in diabetes mellitus].
Tóth L; Szénási P; Varsányi NM; Szilvási I; Kammerer L
Orv Hetil; 1989 Jan; 130(5):223-5. PubMed ID: 2644608
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.
Chung YK; Lee YJ; Kim KW; Cho RK; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
Diab Vasc Dis Res; 2018 Jan; 15(1):24-30. PubMed ID: 29090609
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cystatin C and beta-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella N
J Diabetes Complications; 2003; 17(3):160-8. PubMed ID: 12738401
[TBL] [Abstract][Full Text] [Related]
7. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis.
Zumrutdal A; Sezer S; Demircan S; Seydaoglu G; Ozdemir FN; Haberal M
Nephrology (Carlton); 2005 Oct; 10(5):453-8. PubMed ID: 16221094
[TBL] [Abstract][Full Text] [Related]
8. High levels of serum β2-microglobulin predict severity of coronary artery disease.
You L; Xie R; Hu H; Gu G; Zheng H; Zhang J; Yang X; He X; Cui W
BMC Cardiovasc Disord; 2017 Mar; 17(1):71. PubMed ID: 28249620
[TBL] [Abstract][Full Text] [Related]
9. Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects.
Dullaart RP; Kappelle PJ; de Vries R
Clin Chim Acta; 2012 Dec; 414():161-5. PubMed ID: 23010146
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of albuminuria as predictor for coronary artery stenosis, regardless of estimated glomerular filtration rate, in patients with type 2 diabetes mellitus.
Son JW; Jang EH; Kim MK; Kim HL; Baek KH; Song KH; Yoo SJ; Yoon KH; Cha BY; Lee KW; Son HY; Kwon HS
Am J Cardiol; 2012 Nov; 110(10):1434-9. PubMed ID: 22858190
[TBL] [Abstract][Full Text] [Related]
11. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and carotid atherosclerosis in patients with type 2 diabetes.
Park SW; Kim SK; Cho YW; Kim DJ; Song YD; Choi YJ; Huh BW; Choi SH; Jee SH; Cho MA; Lee EJ; Huh KB
Atherosclerosis; 2009 Jul; 205(1):309-13. PubMed ID: 19147142
[TBL] [Abstract][Full Text] [Related]
13. Proximal tubule dysfunction is dissociated from endothelial dysfunction in normoalbuminuric patients with type 2 diabetes mellitus: a cross-sectional study.
Petrica L; Petrica M; Vlad A; Jianu DC; Gluhovschi G; Ianculescu C; Firescu C; Dumitrascu V; Giju S; Gluhovschi C; Bob F; Gadalean F; Ursoniu S; Velciov S; Bozdog G; Milas O
Nephron Clin Pract; 2011; 118(2):c155-64. PubMed ID: 21150223
[TBL] [Abstract][Full Text] [Related]
14. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.
Wilson AM; Kimura E; Harada RK; Nair N; Narasimhan B; Meng XY; Zhang F; Beck KR; Olin JW; Fung ET; Cooke JP
Circulation; 2007 Sep; 116(12):1396-403. PubMed ID: 17724262
[TBL] [Abstract][Full Text] [Related]
15. The association of smoking and subclinical atherosclerosis in Type 2 diabetes: modification by duration of diabetes.
Karim R; Buchanan TA; Hodis HN; Li Y; Mack WJ
Diabet Med; 2005 Jan; 22(1):81-7. PubMed ID: 15606696
[TBL] [Abstract][Full Text] [Related]
16. Association of pulse pressure with carotid atherosclerosis in patients with type 2 diabetes mellitus.
Wakabayashi I; Masuda H
Blood Press; 2007; 16(1):56-62. PubMed ID: 17453753
[TBL] [Abstract][Full Text] [Related]
17. Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes.
Chuengsamarn S; Rattanamongkolgul S; Jirawatnotai S
J Diabetes Complications; 2014; 28(2):124-9. PubMed ID: 24412514
[TBL] [Abstract][Full Text] [Related]
18. Serum β-2 microglobulin predicts mortality in people with diabetes.
Cheung CL; Lam KS; Cheung BM
Eur J Endocrinol; 2013 Jul; 169(1):1-7. PubMed ID: 23572083
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children.
Herrero-Morín JD; Málaga S; Fernández N; Rey C; Diéguez MA; Solís G; Concha A; Medina A
Crit Care; 2007; 11(3):R59. PubMed ID: 17519026
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
Nakamura A; Shikata K; Hiramatsu M; Nakatou T; Kitamura T; Wada J; Itoshima T; Makino H
Diabetes Care; 2005 Dec; 28(12):2890-5. PubMed ID: 16306550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
